comparemela.com
Home
Live Updates
AstraZeneca Pharma India receives permission for Dapagliflozin tablets : comparemela.com
AstraZeneca Pharma India receives permission for Dapagliflozin tablets
AstraZeneca Pharma India Ltd has received an Import and Market permission in Form CT-20 from the CDSCO , Directorate General of Health Services, Government of India for Dapagliflozin i.e., Forxiga® tablets of 10 mg - additional indication.
Related Keywords
India ,
Dapagliflozin Forxiga ,
Health Services ,
Astrazeneca Pharma India ,
Central Drugs Standard Control Organisation ,
Zeneca Pharma India Limited ,
Subsequent New Drug Approval ,
Directorate General ,
Astrazeneca Pharma India Limited ,
Astrazenecapharmaindia ,
Ine203a01020 ,
Pharmaceuticals ,
Permission ,
Cdsco ,
Dapagliflozin ,
Forxiga ,
comparemela.com © 2020. All Rights Reserved.